ATE334207T1 - CELL CYCLE CHECKPOINT-SPECIFIC GENES - Google Patents
CELL CYCLE CHECKPOINT-SPECIFIC GENESInfo
- Publication number
- ATE334207T1 ATE334207T1 AT96929433T AT96929433T ATE334207T1 AT E334207 T1 ATE334207 T1 AT E334207T1 AT 96929433 T AT96929433 T AT 96929433T AT 96929433 T AT96929433 T AT 96929433T AT E334207 T1 ATE334207 T1 AT E334207T1
- Authority
- AT
- Austria
- Prior art keywords
- cell cycle
- specific genes
- cycle checkpoint
- relates
- polypeptide products
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
This invention relates to a class of checkpoint genes and their polypeptide products which control progression through the cell cycle in eukaryotic cells. In particular this invention relates to Schizosaccharomyces pombe rad3 gene, to its human homologue (ATR) and to their encoded proteins. The invention further relates to assay methods for selecting compounds which modulate the activity of the polypeptide products of these checkpoint genes and the use of the selected compounds in anticancer therapy.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518220.0A GB9518220D0 (en) | 1995-09-06 | 1995-09-06 | Checkpoint gene |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE334207T1 true ATE334207T1 (en) | 2006-08-15 |
Family
ID=35820841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96929433T ATE334207T1 (en) | 1995-09-06 | 1996-09-06 | CELL CYCLE CHECKPOINT-SPECIFIC GENES |
Country Status (3)
Country | Link |
---|---|
AT (1) | ATE334207T1 (en) |
DE (1) | DE69636391D1 (en) |
RU (2) | RU2252256C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2671974C2 (en) * | 2013-03-05 | 2018-11-08 | Ф. Хоффманн-Ля Рош Аг | Method and system for determining biological response of target to soluble candidate substance |
-
1996
- 1996-09-06 AT AT96929433T patent/ATE334207T1/en not_active IP Right Cessation
- 1996-09-06 DE DE69636391T patent/DE69636391D1/en not_active Expired - Lifetime
- 1996-09-06 RU RU98105785/13A patent/RU2252256C2/en not_active IP Right Cessation
-
2004
- 2004-12-30 RU RU2004139232/13A patent/RU2004139232A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2252256C2 (en) | 2005-05-20 |
DE69636391D1 (en) | 2006-09-07 |
RU2004139232A (en) | 2006-06-10 |
MX9801699A (en) | 1998-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR17C1046I2 (en) | NEW B7-4 MOLECULES AND THEIR USES | |
DE69635931D1 (en) | COMPLEMENTARY ADENOVIRENVEKTORSYSTEME AND CELL LINES | |
MX9800719A (en) | Transport proteins and their uses. | |
MX9705039A (en) | Programmed cell death genes and proteins. | |
IL117425A0 (en) | Receptor activation by gas6 | |
TW428026B (en) | Bifunctional protein, preparation and use | |
AU560340B2 (en) | Rennin from recombinant dna | |
DE69233478T8 (en) | NEW HUMAN CDC25 GENES, ENCODED PRODUCTS AND THEIR USE | |
CY1108459T1 (en) | AKT-3 NUCLEAR ACIDS, POLYPALPTESES, AND THEIR USES | |
CA2285667A1 (en) | Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a | |
MX9801264A (en) | Control of cd44 gene expression for therapeutic use. | |
ATE391175T1 (en) | MULTIDRUG RESISTANCE GENE | |
WO1997018323A3 (en) | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity | |
NO972063L (en) | Isolated BMP receptor kinase protein, DNA sequence, recombinant expression vector and host cell | |
ATE334207T1 (en) | CELL CYCLE CHECKPOINT-SPECIFIC GENES | |
HK1002284A1 (en) | Novel implant and novel vector for the treatment of acquired diseases | |
DK0745122T3 (en) | Galnin receptor, nucleic acids, transformed cells and uses thereof | |
ATE364706T1 (en) | NUCLEOTIDE AND PROTEIN SEQUENCE OF MAMMASTATIN AND METHODS OF APPLICATION | |
ATE294862T1 (en) | HUMAN SEL-10 POLYPEPTIDES AND POLYNUCLEOTIDES CODING THEREOF | |
WO1999018203A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS | |
DE69837808D1 (en) | pRb2 / p130 PEPTIDINHIBITORS OF cdk2 KINASEACTIVITY | |
WO2002014369A3 (en) | Human kininogen d5 domain polypeptides and their use | |
BR9407357A (en) | New tripeptides usable in cns and immune therapy | |
WO1999018202A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS | |
BR9911211A (en) | Method for inducing apoptosis in cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |